10-2视野进展定义临床效用的研究
本研究基于模拟和实际青光眼10-2视野数据,评估Guided Progression Analysis定义(GPAD)和簇定义(CBD)的诊断准确性,并提出混合定义。GPAD和CBD特异性分别为99.6%和99.8%,混合定义特异性95.5%,敏感性更高且进展检出时间更早(3.1年 vs 4.2年、4.1年)。
要点
- GPAD和CBD在10-2视野中特异性极高(99.6%和99.8%)。
- 混合定义特异性95.5%,敏感性高于GPAD和CBD。
- 混合定义检出进展时间显著早于GPAD和CBD(3.1年 vs 4.2/4.1年)。
核心结论
- GPAD和CBD特异性分别为99.6%和99.8%。
- 新型混合定义特异性95.5%,敏感性更高且能更早检出进展。
研究设计与样本
- 从664对10-2测试模拟64 400份稳定青光眼视野(数据集1)用于研究特异性及参数影响。
- 收集500只眼共5000份实际10-2测试(数据集2)评估准确性及检出时间。
主要发现
- 数据集1中GPAD和CBD特异性分别为99.6%和99.8%。
- 数据集2中混合定义敏感性高于GPAD和CBD,特异性和假阳性率无劣势。
- 混合定义检出进展时间显著早于GPAD和CBD(3.1年 vs 4.2年和4.1年)。
关键数值与推荐
- 混合定义设计为使特异性最接近95.0%,最终特异性为95.5%。
- 进展检出时间:混合定义3.1年,GPAD 4.2年,CBD 4.1年。
临床怎么用
- 混合定义可在保持较高特异性的同时提高敏感性并更早检出进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIM: To investigate the clinical validity of the Guided Progression Analysis definition (GPAD) and cluster-based definition (CBD) with the Humphrey Field Analyzer 10-2 test in diagnosing glaucomatous visual field (VF) progression, and to introduce a novel definition with optimised specificity by combining the 'any-location' and 'cluster-based' approaches (hybrid definition). METHODS: 64 400 stable glaucomatous VFs were simulated from 664 pairs of 10-2 tests (10 sets × 10 VF series × 664 eyes; data set 1). Using these simulated VFs, the specificity to detect progression and the effects of changing the parameters (number of test locations or consecutive VF tests, and percentile cut-off values) were investigated. The hybrid definition was designed as the combination where the specificity was closest to 95.0%. Subsequently, another 5000 actual glaucomatous 10-2 tests from 500 eyes (10 VFs each) were collected (data set 2), and their accuracy (sensitivity, specificity and false positive rate) and the time needed to detect VF progression were evaluated. RESULTS: The specificity values calculated using data set 1 with GPAD and CBD were 99.6% and 99.8%. Using data set 2, the hybrid definition had a higher sensitivity than GPAD and CBD, without detriment to the specificity or false positive rate. The hybrid definition also detected progression significantly earlier than GPAD and CBD (at 3.1 years vs 4.2 years and 4.1 years, respectively). CONCLUSIONS: GPAD and CBD had specificities of 99.6% and 99.8%, respectively. A novel hybrid definition (with a specificity of 95.5%) had higher sensitivity and enabled earlier detection of progression.
引用
- Asano S, Murata H, Fujino Y, et al. Investigating the clinical usefulness of definitions of progression with 10-2 visual field. Br J Ophthalmol. 2021. PMID: 33674424. doi:10.1136/bjophthalmol-2020-318188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。